Publicacións (42) Publicacións de RICARDO LAGE FERNANDEZ

2024

  1. Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients

    European Journal of Clinical Investigation

2023

  1. Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation

    Cells, Vol. 12, Núm. 4

  2. Gender differences on healthcare accessibility and outcomes of a electronic inter-clinician consultation program at the cardiology department in a Galician Health Area

    European Journal of Clinical Investigation, Vol. 53, Núm. 9

  3. Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

  4. Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  5. The impact of inter-clinician electronic consultation in patients diagnosed with atrial fibrillation in primary care

    European Journal of Clinical Investigation, Vol. 53, Núm. 3

  6. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

    Biomedicine and Pharmacotherapy, Vol. 161

2022

  1. An electronic consultation program impacts on heart failure patients' prognosis: implications for heart failure care

    ESC Heart Failure, Vol. 9, Núm. 6, pp. 4150-4159

  2. Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy

    Cells, Vol. 11, Núm. 2

  3. Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry

    International Journal of Cardiology, Vol. 351, pp. 8-14

  4. MicroRNA-4732-3p Is Dysregulated in Breast Cancer Patients with Cardiotoxicity, and Its Therapeutic Delivery Protects the Heart from Doxorubicin-Induced Oxidative Stress in Rats

    Antioxidants, Vol. 11, Núm. 10

  5. Searching for genetic modulators of the phenotypic heterogeneity in Brugada syndrome

    PLoS ONE, Vol. 17, Núm. 3 March

  6. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

    Frontiers in Pharmacology, Vol. 13

2021

  1. Relaxin has beneficial effects on liver lipidome and metabolic enzymes

    FASEB Journal, Vol. 35, Núm. 7

2020

  1. AMPK-Dependent Mechanisms but Not Hypothalamic Lipid Signaling Mediates GH-Secretory Responses to GHRH and Ghrelin

    Cells, Vol. 9, Núm. 9

  2. Bioelectronics-on-a-chip for cardio myoblast proliferation enhancement using electric field stimulation

    Biomaterials Research, Vol. 24, Núm. 1

2019

  1. Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature

    Journal of Arrhythmia, Vol. 35, Núm. 1, pp. 18-24

  2. FNDC5/Irisin counteracts lipotoxic-induced apoptosis in hypoxic H9c2 cells

    Journal of molecular endocrinology, Vol. 63, Núm. 2, pp. 151-159

  3. Omentin protects H9c2 cells against docetaxel cardiotoxicity

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Validating Left Atrial Low Voltage Areas During Atrial Fibrillation and Atrial Flutter Using Multielectrode Automated Electroanatomic Mapping

    JACC: Clinical Electrophysiology, Vol. 4, Núm. 12, pp. 1541-1552